Deadline: 28-Sep-22
Are you looking for new opportunities to scale up your digital health or medical technology company? Taiwan is a leader in many critical technologies and is a strategic entry point to Asia. The Canadian Technology Accelerator (CTA) business development program is now open for applications to help you foster strategic partnerships.
Benefits
- Graduates of this CTA will walk away with a deeper understanding of the opportunities for their technology in Taiwan and in Asia. They will start initial conversations with potential clients, partners and investors.
-
Upon acceptance to this CTA program, you will access:
- Potential pilot projects, partnerships and investments and sales in Taiwan and Asia
- Trade shows, events and databases highlighting your company's capabilities to a targeted audience of partners and local stakeholders
- Gain introductions and present to potential buyers, strategic partners and investors
How the program works?
-
The CTA program will be delivered online due to COVID-19 travel restrictions. The program includes:
- Market insight webinars and online workshops
- Targeted business-to-business meetings with potential clients, strategic partners and investors
- Opportunities to present at CTA virtual pitch
- Tailored guidance and mentorship from sector experts
- Exclusive events offering networking, showcase booths, speaking opportunities and more
Eligibility Criteria
-
They are seeking innovative Canadian healthcare technology companies in the scale up, business development or investment raising stage. They are looking for innovative health technology (both hardware and software) in areas including:
- Artificial intelligence (AI) assisted algorithm for devices, platforms or systems
- Image analysis technology for diagnostics, monitoring or examination, rehabilitation and therapeutics
- Cloud platforms or blockchain-based application for medical data management
-
Your company must have:
- An innovative and unique minimum viable product or technology with the potential for growth
- Existing market traction – ideally companies that already have successful use cases in North America, Europe or Asia
- Specific goals and a clear strategy to enter Asia
- The Trade Commissioner Service supports equity, diversity and inclusion in trade. They strongly encourage companies led by Canadians of all backgrounds to apply.
Selection criteria
-
CTAs are open to innovative Canadian tech companies that can show they have:
- Marketplace traction: You have a minimum viable product (MVP) and measurable evidence of maturity based on revenue, investment or number of users. Life sciences and health companies must have a proof of concept and be post-seed
- Product-market fit: You can define your target audience, describe the problem your product solves, and show what makes your product or service different from others
- Strong and experienced executive management team: You can commit to send at least one senior member (C-level or founder) to take part in the program and you can cover their in-market costs
- Potential to scale: You have a well-thought-out go-to-market plan for the CTA location, with key performance indicators (KPIs) to match
For more information, visit CTA.
For more information, visit https://www.tradecommissioner.gc.ca/cta-atc/taipei-health-tech-sante.aspx?lang=eng